Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

SELL
$30.32 - $91.33 $350,408 - $1.06 Million
-11,557 Closed
0 $0
Q4 2021

Jan 26, 2022

SELL
$86.26 - $119.0 $1.82 Million - $2.5 Million
-21,045 Reduced 64.55%
11,557 $1.08 Million
Q3 2021

Oct 28, 2021

SELL
$100.17 - $126.36 $6,911 - $8,718
-69 Reduced 0.21%
32,602 $3.63 Million
Q2 2021

Jul 12, 2021

BUY
$86.05 - $119.72 $1.22 Million - $1.7 Million
14,178 Added 76.67%
32,671 $3.71 Million
Q1 2021

May 13, 2021

SELL
$91.47 - $124.36 $606,811 - $825,004
-6,634 Reduced 26.4%
18,493 $1.88 Million
Q4 2020

Feb 26, 2021

BUY
$66.66 - $111.74 $1.67 Million - $2.81 Million
25,127 New
25,127 $2.5 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.